Increasing Market Exclusivity for New Drugs, the Cure for What Ails Us?: Patent Highlight

Por Miller, Chris P.
Publicado em 2012

Quantitative Comparison of Erythropoietin Receptor Levels in the Epithelial versus Endothelial Fractions of Primary Breast Tumors

Por Miller, Chris P., Urban, Nicole, Blau, C. Anthony
Publicado em 2011

Limitations of a Murine Transgenic Breast Cancer Model for Studies of Erythropoietin-Induced Tumor Progression

Por Miller, Chris P, Valliant-Saunders, Karine, Blau, Carl Anthony
Publicado em 2010

A 3D Human Renal Cell Carcinoma-on-a-Chip for the Study of Tumor Angiogenesis()

Por Miller, Chris P., Tsuchida, Connor, Zheng, Ying, Himmelfarb, Jonathan, Akilesh, Shreeram
Publicado no Neoplasia (2018)

MicroRNA expression dynamics during murine and human erythroid differentiation

Por Zhan, Mei, Miller, Chris P, Papayannopoulou, Thalia, Stamatoyannopoulos, George, Song, Chao-Zhong
Publicado em 2007

Engineering Microphysiological Immune System Responses on Chips

Por Miller, Chris P., Shin, Woojung, Ahn, Eun Hyun, Kim, Hyun Jung, Kim, Deok-Ho
Publicado no Trends Biotechnol (2020)

Sparse expression bases in cancer reveal tumor drivers

Por Logsdon, Benjamin A., Gentles, Andrew J., Miller, Chris P., Blau, C. Anthony, Becker, Pamela S., Lee, Su-In
Publicado no Nucleic Acids Res (2015)

Selective Androgen Receptor Modulator RAD140 Is Neuroprotective in Cultured Neurons and Kainate-Lesioned Male Rats

Por Jayaraman, Anusha, Christensen, Amy, Moser, V. Alexandra, Vest, Rebekah S., Miller, Chris P., Hattersley, Gary, Pike, Christian J.
Publicado em 2014

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor

Por Belay, Eyayu, Miller, Chris P., Kortum, Amanda N., Torok-Storb, Beverly, Blau, C. Anthony, Emery, David W.
Publicado no Blood (2015)

Evaluating Erythropoietin-Associated Tumor Progression Using Archival Tissues from a Phase III Clinical Trial

Por Miller, Chris P., Lowe, Kimberly A., Valliant-Saunders, Karine, Kaiser, Joringel F., Mattern, Dominik, Urban, Nicole, Henke, Michael, Blau, C. Anthony
Publicado em 2009

The proteomic landscape of triple-negative breast cancer

Por Lawrence, Robert T., Perez, Elizabeth M., Hernández, Daniel, Miller, Chris P., Haas, Kelsey M., Irie, Hanna Y., Lee, Su-In, Blau, C. Anthony, Villén, Judit
Publicado no Cell Rep (2015)

JAK2 Expression is Associated with Tumor-Infiltrating Lymphocytes and Improved Breast Cancer Outcomes: Implications for Evaluating JAK2 Inhibitors

Por Miller, Chris P., Thorpe, Jason D., Kortum, Amanda N., Coy, Catherine M., Cheng, Wei-Yi, Yang, Tai-Hsien Ou, Anastassiou, Dimitris, Beatty, J. David, Urban, Nicole D., Blau, C. Anthony
Publicado em 2014

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

Por Lee, Su-In, Celik, Safiye, Logsdon, Benjamin A., Lundberg, Scott M., Martins, Timothy J., Oehler, Vivian G., Estey, Elihu H., Miller, Chris P., Chien, Sylvia, Dai, Jin, Saxena, Akanksha, Blau, C. Anthony, Becker, Pamela S.
Publicado no Nat Commun (2018)

Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140

Por Miller, Chris P., Shomali, Maysoun, Lyttle, C. Richard, O’Dea, Louis St. L., Herendeen, Hillary, Gallacher, Kyla, Paquin, Dottie, Compton, Dennis R., Sahoo, Bishwabhusan, Kerrigan, Sean A., Burge, Matthew S., Nickels, Michael, Green, Jennifer L., Katzenellenbogen, John A., Tchesnokov, Alexei, Hattersley, Gary
Publicado em 2010

Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma

Por Siebenthall, Kyle T., Miller, Chris P., Vierstra, Jeff D., Mathieu, Julie, Tretiakova, Maria, Reynolds, Alex, Sandstrom, Richard, Rynes, Eric, Haugen, Eric, Johnson, Audra, Nelson, Jemma, Bates, Daniel, Diegel, Morgan, Dunn, Douglass, Frerker, Mark, Buckley, Michael, Kaul, Rajinder, Zheng, Ying, Himmelfarb, Jonathan, Ruohola-Baker, Hannele, Akilesh, Shreeram
Publicado no EBioMedicine (2019)